CMP Pharma - PharmaKB

Company Reports

Company Reports

Disease Reports

Disease Reports

Company ReportsCMP Pharma

CMP Pharma

Download report

Favorite

Financial

Marketed Drugs

Clinical Trials

Financial

Stock price

No data

Company Revenue

No data

Revenue by Drug

Marketed Drugs

Therapeutic Areas:

All

Classification:

All

Include Generics:

Trade Name	Drug Name	Approved	Patent Expires	Indication
Carospir	Spironolactone	2017-08-04	2036	Heart failure , Hypertension , Liver cirrhosis , Essential hypertension , Nephrotic syndrome , Hyperaldosteronism , Edema , Hypokalemia , Ascites , Hirsutism
Hydrocortisone	Hydrocortisone	1985-09-06	2032-2034	Shock , Ulcerative colitis , Pruritus ani , Inflammation , Adrenal insufficiency , Rheumatic diseases , Status asthmaticus , Contact dermatitis , Facial dermatoses , Hemorrhoids , Congenital adrenal hyperplasia , Foot dermatoses , Hand dermatoses , Scalp dermatoses , Leg dermatoses , Pruritus , Pain , Fissure in ano , Wounds and injuries , Gastrointestinal diseases , Bacterial infections , Pseudomonas infections , Bacterial skin diseases , Skin diseases , Escherichia coli infections , Soft tissue infections , Bacterial eye infections , Urinary bladder diseases , Hepatic encephalopathy , Bacterial meningitis , Bacteremia , Klebsiella infections , Otitis externa , Haemophilus infections , Herpes zoster , Epstein-barr virus infections , Herpes simplex , Herpes labialis , Herpes simplex encephalitis , Aids-related opportunistic infections , Herpes genitalis , Chickenpox , Herpes zoster ophthalmicus , Streptococcal infections , Salmonella infections , Rickettsia infections , Meningococcal meningitis , Bacteroides infections , Acne vulgaris , Gonorrhea , Cholera , Campylobacter infections , Chlamydia infections , Helicobacter infections , Bronchitis , Bartonella infections , Syphilis , Staphylococcal infections , Borrelia infections , Mycoplasma infections , Protozoan infections , Chancroid , Granuloma inguinale , Psittacosis , Pneumonia , Empyema , Pseudomembranous enterocolitis , Neutropenia , Prostatitis , Fever , Urinary tract infections , Sinusitis , Typhoid fever , Diarrhea , Intraabdominal infections , Osteomyelitis , Bacterial conjunctivitis , Infectious arthritis , Pyelonephritis , Proteus infections , Anthrax , Cystitis , Dysentery , Gram-positive bacterial infections
Isoniazid	Isoniazid	1983-11-10		Tuberculosis , Mycobacterium infections , Bacterial infections , Legionnaires' disease , Staphylococcal infections , Bacterial meningitis , Brucellosis , Aids-related opportunistic infections , Leprosy , Haemophilus infections
Norliqva	Amlodipine besylate	2022-02-24		—
Polystyrene sulfonate	Polystyrene sulfonic acid	1989-01-19		—
Sps	Polystyrene sulfonic acid	1982-12-08		—
Tadliq	Tadalafil	2022-06-17	2038	Pulmonary hypertension, Erectile dysfunction, Vasculogenic impotence, Prostatic neoplasms, Prostatic hyperplasia, Alopecia, Hirsutism
Trianex	Triamcinolone	1995-03-23	2027-2034	Atopic dermatitis, Ulcerative colitis, Ankylosing spondylitis, Nephrotic syndrome, Multiple sclerosis, Uveitis, Inflammation, Pulmonary tuberculosis, Adrenal insufficiency, Systemic lupus erythematosus, Rheumatic diseases, Allergic rhinitis perennial, Synovitis, Facial dermatoses, Thyroiditis, Hypercalcemia, Hemolytic anemia, Pemphigus, Berylliosis, Bronchial spasm, Foot dermatoses, Dermatitis herpetiformis, Hand dermatoses, Erythema multiforme, Scalp dermatoses, Serum sickness, Leg dermatoses, Mycoses, Oral candidiasis, Vulvovaginal candidiasis, Cutaneous candidiasis, Chronic mucocutaneous candidiasis, Bacterial infections, Bacterial skin diseases, Escherichia coli infections, Hepatic encephalopathy
Atorvaliq	Atorvastatin	2023-02-01	2037	Hypercholesterolemia, Coronary artery disease, Hypertriglyceridemia, Hyperlipoproteinemias, Hypertension, Variant angina pectoris, Familial combined hyperlipidemia, Hyperlipoproteinemia type ii
Liqrev	Sildenafil	2023-04-28	2038	Pulmonary hypertension, Erectile dysfunction, Vasculogenic impotence

Clinical Trials

Therapeutic Areas:

All

Classification:

All

Approval:

All

Status:

All

Phases:

All

Drug Name

Phase 1

Phase 2

Phase 3

Phase 4

Indication

healthy volunteers/patients

,

diabetic nephropathies

,

kidney diseases

,

diabetes mellitus

,

,

type 2 diabetes mellitus

,

glucose intolerance

,

,

hypercholesterolemia

,

Canrenoate potassium

,

atrial fibrillation

,

cardiac arrhythmias

myeloid leukemia acute

© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use